These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 21477702)

  • 21. Daptomycin in the treatment of bacteremia.
    Sakoulas G; Golan Y; Lamp KC; Friedrich LV; Russo R
    Am J Med; 2007 Oct; 120(10 Suppl 1):S21-7. PubMed ID: 17904947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections.
    Kanafani ZA; Corey GR
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):177-84. PubMed ID: 17402833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Daptomycin experience in critical care patients: results from a registry.
    Brown JE; Fominaya C; Christensen KJ; McConnell SA; Lamp KC
    Ann Pharmacother; 2012 Apr; 46(4):495-502. PubMed ID: 22454446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current use of daptomycin in cardiac surgery and postoperative intensive care.
    Kanzler I; Weis F; Beiras-Fernandez A
    Expert Rev Anti Infect Ther; 2013 Mar; 11(3):309-20. PubMed ID: 23458770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness and safety of daptomycin in complicated skin and soft-tissue infections and bacteraemia in clinical practice: results of a large non-interventional study.
    Gonzalez-Ruiz A; Beiras-Fernandez A; Lehmkuhl H; Dohmen PM; Loeffler J; Chaves RL
    Int J Antimicrob Agents; 2013 Apr; 41(4):372-8. PubMed ID: 23499225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Daptomycin in the treatment of Gram-positive infections in patients with chronic renal failure].
    Sarriá Cepeda C
    Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():38-42. PubMed ID: 22541974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacoeconomic assessment of daptomycin as first-line therapy for bacteraemia and complicated skin and skin structure infections caused by gram-positive pathogens in Spain].
    Grau S; Rebollo P; Cuervo J; Gil-Parrado S
    Rev Esp Quimioter; 2011 Sep; 24(3):154-63. PubMed ID: 21947099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daptomycin is safe and effective for the treatment of gram-positive cocci infections in solid organ transplantation.
    Len O; Montejo M; Cervera C; Fariñas MC; Sabé N; Ramos A; Cordero E; Torre-Cisneros J; Martín-Dávila P; Azanza JR; Pahissa A; Gavaldà J;
    Transpl Infect Dis; 2014 Aug; 16(4):532-8. PubMed ID: 24834833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Daptomycin: pharmacological characteristics and its role in the treatment of gram positive infections].
    Araos R; García P; Chanqueo L; Labarca J
    Rev Chilena Infectol; 2012 Apr; 29(2):127-31. PubMed ID: 22689024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients.
    Chaftari AM; Hachem R; Mulanovich V; Chemaly RF; Adachi J; Jacobson K; Jiang Y; Raad I
    Int J Antimicrob Agents; 2010 Aug; 36(2):182-6. PubMed ID: 20452752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daptomycin.
    Enoch DA; Bygott JM; Daly ML; Karas JA
    J Infect; 2007 Sep; 55(3):205-13. PubMed ID: 17629567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Challenges in the antimicrobial treatment of infective endocarditis. Role of daptomycin].
    Almirante B; Miró JM
    Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():26-32. PubMed ID: 22541972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical utility of daptomycin in infective endocarditis caused by Gram-positive cocci.
    Cervera C; Castañeda X; Pericas JM; Del Río A; de la Maria CG; Mestres C; Falces C; Marco F; Moreno A; Miró JM
    Int J Antimicrob Agents; 2011 Nov; 38(5):365-70. PubMed ID: 21420835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of daptomycin in patients with renal impairment: a multicenter retrospective analysis.
    Kullar R; McClellan I; Geriak M; Sakoulas G
    Pharmacotherapy; 2014 Jun; 34(6):582-9. PubMed ID: 24658897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Daptomycin in the treatment of skin, soft-tissue and invasive infections due to Gram-positive bacteria.
    Johnson A
    Future Microbiol; 2006 Oct; 1(3):255-65. PubMed ID: 17661638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Daptomycin for the treatment of infective endocarditis: results from a European registry.
    Dohmen PM; Guleri A; Capone A; Utili R; Seaton RA; González-Ramallo VJ; Pathan R; Heep M; Chaves RL
    J Antimicrob Chemother; 2013 Apr; 68(4):936-42. PubMed ID: 23190763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Safety and efficacy of daptomycin therapy in older adults with pluripathology].
    Parra-Ruiz J; Hernández-Quero J
    Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():50-3. PubMed ID: 22541976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brazilian experience in EU-CORE: daptomycin registry and treatment of serious Gram-positive infections.
    Timerman A; Brites C; Bicudo E; Grinbaum RS; Costa Filho R; Carrilho CD; Bichels A; Barreto T
    Braz J Infect Dis; 2013; 17(6):647-53. PubMed ID: 23916455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria.
    Rybak MJ
    Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():24-32. PubMed ID: 16445721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal septicaemia in Ilorin: bacterial pathogens and antibiotic sensitivity pattern.
    Mokuolu AO; Jiya N; Adesiyun OO
    Afr J Med Med Sci; 2002 Jun; 31(2):127-30. PubMed ID: 12518907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.